Last reviewed · How we verify
Bone Marrow Concentrate treatment
At a glance
| Generic name | Bone Marrow Concentrate treatment |
|---|---|
| Sponsor | Regenexx, LLC |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Procedural pain
- Arthralgia
- Joint swelling
- Joint stiffness
- Post procedural contusion
- Post procedural haematoma
Key clinical trials
- Orthobiological Therapies in Musculoskeletal Disorders (EARLY_PHASE1)
- Arthroscopic Treatment of Acetabular Labral Lesions: Intrarticular Injection of Bone Marrow vs Hip Arthroscopy Alone (NA)
- Bone Marrow Versus Adipose Tissue as a Cell Source for Infiltrative Treatment of Knee Osteoarthritis (NA)
- Acellular Matrix From Human Dermis in Combination With Orthobiologic Stimuli for Augmentation of Massive Rotator Cuff Tears (NA)
- Biologic Injection For Adults With Lumbar Disc Herniation (NA)
- Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis (NA)
- HyaloFAST Trial for Repair of Articular Cartilage in the Knee (NA)
- CAM Procedure With BMAC for Shoulder OA (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bone Marrow Concentrate treatment CI brief — competitive landscape report
- Bone Marrow Concentrate treatment updates RSS · CI watch RSS
- Regenexx, LLC portfolio CI